Timo Gemoll
Impact in
-
- Cancer Genomics and Diagnostics
-
- Inflammatory Biomarkers in Disease Prognosis
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Epigenetics and DNA Methylation 3
- Extracellular vesicles in disease 3
-
- Cancer Genomics and Diagnostics 4
- Co-authors
- Jens K. Habermann (31 shared papers)Uwe J. Roblick (12 shared papers)Gert Auer (15 shared papers)Thomas Ried (10 shared papers)Christoph Thorns (7 shared papers)Hans‐Peter Bruch (8 shared papers)Hans Jörnvall (7 shared papers)Susanne Becker (6 shared papers)
- Journals
- Oncotarget (4 papers)Cellular and Molecular Life Sciences (3 papers)Scientific Reports (2 papers)Journal of Clinical Medicine (2 papers)International Journal of Molecular Sciences (2 papers)
- Partner nations
- GermanySwedenUnited States
In The Last Decade
Timo Gemoll
43 papers receiving 562 citations
Peers
Comparison fields: 5 of 78
- Cancer Research 135
- Oncology 145
- Spectroscopy 73
- Molecular Biology 253
- Immunology 74
Countries citing papers authored by Timo Gemoll
This map shows the geographic impact of Timo Gemoll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timo Gemoll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timo Gemoll more than expected).
Fields of papers citing papers by Timo Gemoll
This network shows the impact of papers produced by Timo Gemoll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timo Gemoll. The network helps show where Timo Gemoll may publish in the future.
Co-authors
The 25 scholars most cited alongside Timo Gemoll, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 65 | |
| 2 | 2015 | 44 | |
| 3 | 2012 | 37 | |
| 4 | 2012 | 31 | |
| 5 | 2015 | 28 | |
| 6 | 2010 | 26 | |
| 7 | 2016 | 25 | |
| 8 | 2007 | 23 | |
| 9 | 2019 | 22 | |
| 10 | 2021 | 21 | |
| 11 | 2017 | 20 | |
| 12 | 2011 | 20 | |
| 13 | 2017 | 18 | |
| 14 | 2011 | 18 | |
| 15 | 2020 | 17 | |
| 16 | 2013 | 15 | |
| 17 | 2013 | 14 | |
| 18 | 2023 | 12 | |
| 19 | 2022 | 10 | |
| 20 | 2020 | 9 |
About Timo Gemoll
Timo Gemoll is a scholar working on Molecular Biology, Cancer Research, Spectroscopy, Oncology and Cell Biology, having authored 45 papers that have together received 569 indexed citations. Recurring topics across this work include Advanced Proteomics Techniques and Applications (7 papers), Microtubule and mitosis dynamics (4 papers), Cancer Genomics and Diagnostics (4 papers), Epigenetics and DNA Methylation (3 papers), Extracellular vesicles in disease (3 papers), Mass Spectrometry Techniques and Applications (3 papers), Genetic factors in colorectal cancer (3 papers) and Immune cells in cancer (2 papers). The work is most often cited by research in Cancer Research (135 citations), Oncology (145 citations), Spectroscopy (73 citations), Molecular Biology (253 citations) and Immunology (74 citations). Timo Gemoll has collaborated with scholars based in Germany, Sweden and United States. Frequent co-authors include Jens K. Habermann, Uwe J. Roblick, Gert Auer, Thomas Ried, Christoph Thorns, Hans‐Peter Bruch, Hans Jörnvall, Susanne Becker, Sonja Hartwig and Silke Szymczak. Their work appears in journals such as Oncotarget, Cellular and Molecular Life Sciences, Scientific Reports, Journal of Clinical Medicine and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.